Clinically significant urethral stricture and/or subclinical urethral stricture after high-intensity focused ultrasound correlates with disease-free survival in patients with localized prostate cancer

Urologia Internationalis

Volumn 87, Issue 3, 2011, Pages 276-281

  Komura, Kazumasa ^a   Inamoto, Teruo ^a   Black, Peter C ^c   Fujisue, Yutaka ^a   Katsuoka, Yoji ^a   Watsuji, Toshikazu ^b   Azuma, Haruhito ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b Hirakata City Hospital   (Japan)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

High intensity focused ultrasound; Localized prostate cancer; Urethral stricture, prognosis

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BLADDER CATHETERIZATION; BLADDER NECK STENOSIS; CANCER STAGING; CANCER SURVIVAL; CYSTOTOMY; DISEASE FREE SURVIVAL; ENDOSCOPIC SURGERY; FOLLOW UP; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; HUMAN TISSUE; INCISION; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE CANCER; SUBCLINICAL URETHRAL STRICTURE; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME; URETHRA STRICTURE;

AGED; BIOPSY; COHORT STUDIES; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONIC THERAPY; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL; URETHRAL STRICTURE;

EID: 80055057395     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000330909     Document Type: Article

References (15)

1. Uchida T, Shoji S, Nakano M, Hongo S, Nitta M, Murota A, Nagata Y: Transrectal highintensity focused ultrasound for the treatment of localized prostate cancer: Eight-year experience. Int J Urol 2009; 16: 881-886.
2. Challacombe BJ, Murphy DG, Zakri R, Cahill DJ: High-intensity focused ultrasound for localized prostate cancer: Initial experience with a 2-year follow-up. BJU Int 2009; 104: 200-204.
3. Gelet A, Chapelon JY, Bouvier R, Rouviere O, Lyonnet D, Dubernard JM: Transrectal highintensity focused ultrasound for the treatment of localized prostate cancer: Factors influencing the outcome. Eur Urol 2001; 40: 124-129.
4. Madersbacher S, Pedevilla M, Vingers L, Susani M, Marberger M: Effect of high-intensity focused ultrasound on human prostate cancer in vivo. Cancer Res 1995; 55: 3346-3351.
5. Roach M 3rd, Hanks G, Thames H Jr, Schellhammer P, Shipley WU, Sokol GH, Sandler H: Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006; 65: 965-974.
6. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969-974.
7. Ahmed HU, Zacharakis E, Dudderidge T, Armitage JN, Scott R, Calleary J, Illing R, Kirkham A, Freeman A, Ogden C, Allen C, Emberton M: High-intensity-focused ultrasound in the treatment of primary prostate cancer: The first UK series. Br J Cancer 2009; 101: 19-26.
8. Blana A, Hierl J, Rogenhofer S, Lunz JC, Wieland WF, Walter B, Bach T, Ganzer R: Factors predicting for formation of bladder outlet obstruction after high-intensity focused ultrasound in treatment of localized prostate cancer. Urology 2008; 71: 863-867.
9. Mearini L, D'Urso L, Collura D, Zucchi A, Costantini E, Formiconi A, Bini V, Muto G, Porena M: Visually directed transrectal high intensity focused ultrasound for the treatment of prostate cancer: A preliminary report on the Italian experience. J Urol 2009; 181: 105-111.
10. Poissonnier L, Chapelon JY, Rouviere O, Curiel L, Bouvier R, Martin X, Dubernard JM, Gelet A: Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol 2007; 51: 381-387.
11. Chaussy C, Thuroff S: The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection. Curr Urol Rep 2003; 4: 248-252.
12. Vallancien G, Prapotnich D, Cathelineau X, Baumert H, Rozet F: Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: Feasibility study. J Urol 2004; 171: 2265-2267.
13. American Society for Therapeutic Radiology and Oncology Consensus Panel: Consensus statement: Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 1997; 37: 1035-1041.
14. Ganzer R, Rogenhofer S, Walter B, Lunz JC, Schostak M, Wieland WF, Blana A: PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound treatment of localised prostate cancer. Eur Urol 2008; 53: 547-553.
15. Sumitomo M, Hayashi M, Watanabe T, Tsugawa M, Noma H, Yamaguchi A, Nagakura K, Hayakawa M, Uchida T: Efficacy of shortterm androgen deprivation with high-intensity focused ultrasound in the treatment of prostate cancer in Japan. Urology 2008; 72: 1335-1340.